Wierenga Wendell
- SEC CIK
- 0001239956
In the past year, 3 open-market sale filings worth $1.88M and no purchases.
Current role at each company
- CRNX Crinetics Pharmaceuticals, Inc.Directoras of Sep 1, 2026
- CYTK Cytokinetics IncDirectoras of Jul 16, 2026
- DRMA Dermata Therapeutics, Inc.Directoras of Jan 6, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.88M
- 3 filings
- Net
- −$1.88M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Wierenga Wendell as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CYTK Cytokinetics Inc
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 (view filing) | May 5 | Same day | Wierenga WendellDirector | SSale | −4.03K | $75.00 | −$302.4K | −11.0%32.6K after | 10b5-1 |
| Dec 23, 2025 (view filing) | Dec 22 | 1 day | Wierenga WendellDirector | SSale | −20.0K | $66.14 | −$1.32M | −38.1%32.4K after | 10b5-1 |
| Oct 27, 2025 (view filing) | Oct 27 | Same day | Wierenga WendellDirector | SSale | −4.38K | $58.68 | −$256.7K | −11.9%32.4K after | 10b5-1 |